BioCentury
ARTICLE | Company News

Aegerion, QLT deal

June 20, 2016 7:00 AM UTC

Aegerion and QLT will merge to form newco Novelion Therapeutics Inc. Aegerion shareholders will receive 1.0256 QLT shares for each Aegerion share and own about 33% of the combined newco. QLT shareholders will own the remaining 67%. QLT will loan Aegerion up to $15 million for working capital needs. ...